<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Galantamine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00674</strong>&#160; (APRD00206, EXPT01628)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A benzazepine derived from norbelladine. It is found in galanthus and other amaryllidaceae. Galantamine is a cholinesterase inhibitor that has been used to reverse the muscular effects of gallamine triethiodide and tubocurarine, and has been studied as a treatment for Alzheimer&#8217;s disease and other central nervous system disorders. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00674/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00674/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00674.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00674.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00674.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00674.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00674.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00674">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>(-)-Galanthamine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Galanthamine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Galantamine hydrobromide</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000316/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000316/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: QORVDGQLPPAFRS-XPSHAMGMSA-N</li>
              <li>Monoisotopic Mass: 367.078306222</li>
              <li>Average Mass: 368.265</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000316">DBSALT000316</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Lycoremine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nivalin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Razadyne</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Reminyl</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/nootropic-agents">Nootropic Agents</a></li>
<li><a href="/mesh/cholinesterase-inhibitors">Cholinesterase Inhibitors</a></li>
<li><a href="/mesh/parasympathomimetics">Parasympathomimetics</a></li></ul></td></tr><tr><th>CAS number</th><td>357-70-0</td></tr><tr><th>Weight</th><td>Average: 287.3535<br>Monoisotopic: 287.152143543</td></tr><tr><th>Chemical Formula</th><td>C<sub>17</sub>H<sub>21</sub>NO<sub>3</sub></td></tr><tr><th>InChI Key</th><td>ASUTZQLVASHGKV-JDFRZJQESA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Benzazepines</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Benzazepines</td></tr><tr><th>Alternative parents</th><td>Benzofurans; Anisoles; Alkyl Aryl Ethers; Azepines; Tertiary Amines; Secondary Alcohols; Polyamines</td></tr><tr><th>Substituents</th><td>benzofuran; anisole; phenol ether; alkyl aryl ether; azepine; benzene; secondary alcohol; tertiary amine; ether; polyamine; amine; alcohol; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom).</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of mild to moderate dementia of the Alzheimer's type. Has also been investigated in patients with mild cognitive impairment who did not meet the diagnostic criteria for Alzheimer's disease.</td></tr><tr><th>Pharmacodynamics</th><td>Galantamine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. It is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. An early pathophysiological feature of Alzheimer's disease that is associated with memory loss and cognitive deficits is a deficiency of acetylcholine as a result of selective loss of cholinergic neurons in the cerebral cortex, nucleus basalis, and hippocampus. Galantamine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, Galantamine's effect may lessen as the disease progresses and fewer cholinergic neurons remain functionally intact. There is no evidence that Galantamine alters the course of the underlying dementing process.</td></tr><tr><th>Mechanism of action</th><td>Galantamine is a phenanthrene alkaloid and a reversible, competitive acetylcholinesterase inhibitor. It is not structurally related to other acetylcholinesterase inhibitors. Galantamine's proposed mechanism of action involves the reversible inhibition of acetylcholinesterase, which prevents the hydrolysis of acetycholine, leading to an increased concentration of acetylcholine at cholinergic synapses. Galantamine also binds allosterically with nicotinic acetylcholine receptors and may possibly potentiate the action of agonists (such as acetylcholine) at these receptors.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>175 L</li>
</ul></td></tr><tr><th>Protein binding</th><td>18%</td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td>Galantamine is metabolized by hepatic cytochrome P450 enzymes, glucuronidated, and excreted unchanged in the urine.</td></tr><tr><th>Half life</th><td>7 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>300 mL/min [After IV. or oral administration]</li>
</ul></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub>=75 mg/kg (rat)</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9959</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8259</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.8976</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.6069</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9443</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Inhibitor
        </td>
        <td>0.5728</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8072</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.8919</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.7408</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9046</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9071</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.5414</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8301</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8832</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9439</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.7995
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9055
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            1.0
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.7790 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8023
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7424
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Barr laboratories inc</li>
<li>Impax laboratories inc</li>
<li>Watson laboratories inc</li>
<li>Ortho mcneil janssen pharmaceuticals inc</li>
<li>Roxane laboratories inc</li>
<li>Ortho mcneil janssen pharmaceutical inc</li>
<li>Actavis elizabeth llc</li>
<li>Beijing yabao biopharmaceutical co ltd</li>
<li>Dr reddys laboratories ltd</li>
<li>Mylan pharmaceuticals inc</li>
<li>Sandoz inc</li>
<li>Teva pharmaceuticals usa</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.alphapharm.com.au">Alphapharm Party Ltd.</a></li>
<li>Barr Pharmaceuticals</li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>DispenseXpress Inc.</li>
<li><a href="http://www.drreddys.com">Doctor Reddys Laboratories Ltd.</a></li>
<li><a href="http://www.globalphar.com">Global Pharmaceuticals</a></li>
<li>Heartland Repack Services LLC</li>
<li><a href="http://www.impaxlabs.com">Impax Laboratories Inc.</a></li>
<li><a href="http://www.janssen-ortho.com">Janssen-Ortho Inc.</a></li>
<li>Kaiser Foundation Hospital</li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho Mcneil Janssen Pharmaceutical Inc.</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho-McNeil-Janssen Pharmaceuticals Inc.</a></li>
<li><a href="http://www.patriotpharmaceuticals.com">Patriot Pharmaceuticals</a></li>
<li><a href="http://www.pplpho.org">Physician Partners Ltd.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Resource Optimization and Innovation LLC</li>
<li><a href="http://www.roxane.com">Roxane Labs</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.udllabs.com">UDL Laboratories</a></li>
<li>Vangard Labs Inc.</li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Capsule, extended release</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Galantamine Hydrobromide 30 16 mg 24 Hour Capsule Bottle</td><td>198.58USD</td><td>bottle</td></tr><tr><td>Galantamine Hydrobromide 30 8 mg 24 Hour Capsule Bottle</td><td>198.58USD</td><td>bottle</td></tr><tr><td>Razadyne 12 mg tablet</td><td>8.3USD</td><td>tablet</td></tr><tr><td>Razadyne 4 mg tablet</td><td>5.36USD</td><td>tablet</td></tr><tr><td>Razadyne 8 mg tablet</td><td>3.66USD</td><td>tablet</td></tr><tr><td>Galantamine hbr 12 mg tablet</td><td>3.18USD</td><td>tablet</td></tr><tr><td>Galantamine hbr 4 mg tablet</td><td>3.18USD</td><td>tablet</td></tr><tr><td>Galantamine hbr 8 mg tablet</td><td>3.18USD</td><td>tablet</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="patents"><thead><tr><th>Country</th><th>Patent Number</th><th>Approved</th><th>Expires (estimated)</th></tr></thead><tbody><tr><td>United States</td><td>7160559</td><td>1999-12-20</td><td>2019-12-20</td></tr><tr><td>United States</td><td>6099863</td><td>1997-06-06</td><td>2017-06-06</td></tr><tr><td>Canada</td><td>2358062</td><td>2006-12-19</td><td>2019-12-20</td></tr><tr><td>Canada</td><td>2310926</td><td>2001-11-20</td><td>2017-06-06</td></tr></tbody></table></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>269-270 &#176;C (HBr salt)</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>water solubility</td><td>10 mg/mL (HBr salt)</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>logP</td><td>1.8</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>1.70e+00 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>1.39</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>1.16</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-2.2</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>14.81</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>8.91</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>41.93</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>82.3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>31.4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Vijaya Bolugoddu, Sanjay Shukla, Mukunda Jambula, Rajeshwar Sagyam, Ramchandra Pingili, Ananda Thirunavakarasu, &#8220;Preparation of (-)-galantamine hydrobromide.&#8221; U.S. Patent US20060009640, issued January 12, 2006.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=20060009640&amp;tbm=pts" target="_blank">US20060009640 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer&#8217;s disease. Drugs. 2000 Nov;60(5):1095-122. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11129124">Pubmed</a></li>
	<li>Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL: Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. <span class="caps">FEBS</span> Lett. 1999 Dec 17;463(3):321-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10606746">Pubmed</a></li>
	<li>Woodruff-Pak DS, Vogel RW 3rd, Wenk GL: Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94. Epub 2001 Feb 6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11172080">Pubmed</a></li>
	<li>Birks J: Cholinesterase inhibitors for Alzheimer&#8217;s disease. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16437532">Pubmed</a># Lilienfeld S: Galantamine&#8212;a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer&#8217;s disease. <span class="caps">CNS</span> Drug Rev. 2002 Summer;8(2):159-76. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12177686">Pubmed</a></li>
	<li>Olin J, Schneider L: Galantamine for Alzheimer&#8217;s disease. Cochrane Database Syst Rev. 2002;(3):CD001747. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12137632">Pubmed</a># Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer&#8217;s disease. Drugs. 2000 Nov;60(5):1095-122. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11129124">Pubmed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D04292" target="_blank">D04292 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C08526" target="_blank">C08526 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=908828" target="_blank">908828 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505659" target="_blank">46505659 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.23175565.html" target="_blank">23175565 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>BindingDB</td><td><a class="wishart-link-out" href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10404" target="_blank">10404 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=5264" target="_blank">5264 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL659" target="_blank">CHEMBL659 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000559" target="_blank">DAP000559 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA449726" target="_blank">PA449726 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>HET</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/msd-srv/chempdb/cgi-bin/cgi.pl?FUNCTION=getByCode&amp;CODE=GNT" target="_blank">GNT <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=2266717" target="_blank">2266717 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/reminyl.htm" target="_blank">http://www.rxlist.com/cgi/generic/reminyl.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/cdi/galantamine.html" target="_blank">http://www.drugs.com/cdi/galantamine.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Galantamine" target="_blank">Galantamine <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>N06DA04<ul class="atc-drug-tree"><li><a href="/atc/N#N">N &#8212; NERVOUS SYSTEM</a></li><li><a href="/atc/N06#N06">N06 &#8212; PSYCHOANALEPTICS</a></li><li><a href="/atc/N06D#N06D">N06D &#8212; ANTI-DEMENTIA DRUGS</a></li><li><a href="/atc/N06DA#N06DA">N06DA &#8212; Anticholinesterases</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>12:04.00</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00674.pdf?1265922798">show</a>(278 KB)</td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00674.pdf?1265922738">show</a>(28.4 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01614">Acepromazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01615">Aceprometazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01246">Alimemazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01616">Alverine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00915">Amantadine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00321">Amitriptyline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00543">Amoxapine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00572">Atropine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00719">Azatadine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00245">Benzatropine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00810">Biperiden</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00835">Brompheniramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00748">Carbinoxamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01114">Chlorphenamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00477">Chlorpromazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01239">Chlorprothixene</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00283">Clemastine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00771">Clidinium</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01242">Clomipramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00363">Clozapine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01176">Cyclizine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00924">Cyclobenzaprine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00434">Cyproheptadine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00496">Darifenacin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01151">Desipramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00405">Dexbrompheniramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00804">Dicyclomine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00985">Dimenhydrinate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01075">Diphenhydramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01081">Diphenoxylate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01146">Diphenylpyraline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00280">Disopyramide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01142">Doxepin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00366">Doxylamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00392">Ethopropazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01148">Flavoxate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00875">Flupentixol</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01437">Glutethimide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00986">Glycopyrrolate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00557">Hydroxyzine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00424">Hyoscyamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00458">Imipramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01247">Isocarboxazid</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01625">Isopropamide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01026">Ketoconazole</a></td><td>Ketoconazole increases the effect and toxicity of galantamine</td></tr><tr><td><a href="/drugs/DB00408">Loxapine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00934">Maprotiline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00737">Meclizine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00933">Mesoridazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00902">Methdilazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01403">Methotrimeprazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00462">Methylscopolamine bromide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00370">Mirtazapine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01171">Moclobemide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01618">Molindone</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00540">Nortriptyline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00334">Olanzapine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01173">Orphenadrine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01062">Oxybutynin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00715">Paroxetine</a></td><td>Paroxetine increases the effect and toxicity of galantamine</td></tr><tr><td><a href="/drugs/DB00850">Perphenazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00454">Pethidine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00780">Phenelzine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01619">Phenindamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01100">Pimozide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01621">Pipotiazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01035">Procainamide</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00433">Prochlorperazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00387">Procyclidine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00420">Promazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01069">Promethazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00782">Propantheline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01608">Propericiazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00344">Protriptyline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01224">Quetiapine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00908">Quinidine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00734">Risperidone</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00747">Scopolamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01104">Sertraline</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01591">Solifenacin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01622">Thioproperazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00679">Thioridazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01623">Thiothixene</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00697">Tizanidine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01036">Tolterodine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00752">Tranylcypromine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00656">Trazodone</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00831">Trifluoperazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00508">Triflupromazine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00376">Trihexyphenidyl</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00662">Trimethobenzamide</a></td><td>The therapeutic effects of the anticholinergic, Trimethobenzamide, and/or the acetylcholinesterase inhibitor (central), Galantamine, may be reduced due to antagonism. Monitor therapeutic effects of both agents.</td></tr><tr><td><a href="/drugs/DB00726">Trimipramine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00792">Tripelennamine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00427">Triprolidine</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00209">Trospium</a></td><td>The therapeutic effects of the anticholinergic, Trospium, and/or the acetylcholinesterase inhibitor (central), Galantamine, may be reduced due to antagonism. Monitor therapeutic effects of both agents.</td></tr><tr><td><a href="/drugs/DB00246">Ziprasidone</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01624">Zuclopenthixol</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB08919">Zuclopenthixol acetate</a></td><td>Possible antagonism of action.</td></tr><tr><td><a href="/drugs/DB08920">Zuclopenthixol decanoate</a></td><td>Possible antagonism of action.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Take with food.</li></ul></td></tr></tbody></table>